Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,278 | 23,550 | 43,145 | 70,903 | 15,173 |
| TOTAL | $5,194 | $26,273 | $45,596 | $72,497 | $17,198 |
| Non-Current Assets | |||||
| PPE Net | 159 | 272 | 275 | 338 | 483 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| Other Non-Current Assets | 424 | 524 | 403 | 107 | 202 |
| TOTAL | $11,731 | $11,944 | $11,826 | $11,593 | $11,833 |
| Total Assets | $16,925 | $38,217 | $57,422 | $84,090 | $29,031 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,359 | 6,815 | 4,819 | 3,622 | 2,920 |
| TOTAL | $5,359 | $6,815 | $4,819 | $3,622 | $2,920 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,587 | 5,329 | 412 | 1,475 | 8,351 |
| TOTAL | $5,587 | $5,329 | $412 | $1,475 | $8,351 |
| Total Liabilities | $10,946 | $12,144 | $5,231 | $5,097 | $11,271 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,000 | 149 | 1,909 | 1,906 | 1,897 |
| Common Shares | 3 | 33 | 29 | 29 | 69 |
| Retained earnings | -153,367 | -131,604 | -101,835 | -72,810 | -56,916 |
| Other shareholders' equity | -41 | -9 | 12 | 41 | -64 |
| TOTAL | $5,979 | $26,073 | $52,191 | $78,993 | $17,760 |
| Total Liabilities And Equity | $16,925 | $38,217 | $57,422 | $84,090 | $29,031 |